NISA INVESTMENT ADVISORS, LLC

Position in COGT — Cogent Biosciences, Inc.

CIK 937615 ST. LOUIS, MO

Position in COGT

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$146,015

-$77,804 QoQ

Shares Held

3,773

-35.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#256

of 321 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. COGT ranks #42 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$146,015	3,773	-35.1%	Shares	Sole	2026-08-10
2026-03-31	$223,819	5,815	+213.5%	Shares	Sole	2026-04-30
2025-12-31	$65,889	1,855	+35.7%	Shares	Sole	2026-01-15
2025-09-30	$19,630	1,367	+0.7%	Shares	Sole	2025-10-23
2025-06-30	$9,743	1,357	+8.0%	Shares	Sole	2025-07-31
2025-03-31	$7,529	1,257	-7.8%	Shares	Sole	2025-04-30
2024-12-31	$10,631	1,363	+7.9%	Shares	Sole	2025-01-17
2024-09-30	$13,640	1,263	+4.4%	Shares	Sole	2024-10-24
2024-06-30	$10,200	1,210	+10.5%	Shares	Sole	2024-07-19
2024-03-31	$7,358	1,095	+3.8%	Shares	Sole	2024-05-02
2023-12-31	$6,203	1,055	-42.2%	Shares	Sole	2024-01-25
2023-09-30	$17,793	1,825	+73.1%	Shares	Sole	2023-11-02
2023-06-30	$12,479	1,054	+13075.0%	Shares	Sole	2023-08-11
2023-03-31	$86	8	0.0%	Shares	Sole	2023-05-02
2022-12-31	$92	8	-84.0%	Shares	Sole	2023-02-02
2022-09-30	$746	50	—	Shares	Sole	2022-11-07
No filing history on record for this holder in this stock.